1887

Emerging Infections 9

Editors: W. Michael Scheld1, M. Lindsay Grayson2, James M. Hughes3
VIEW AFFILIATIONS HIDE AFFILIATIONS
Affiliations: 1: Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia; 2: Infectious Diseases Department, Austin Health and Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia; 3: Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia
Content Type: Monograph
Format: Electronic, Hardcover
Publication Year: 2010

Category: Clinical Microbiology; Bacterial Pathogenesis

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this book:
Buy

Since 1995, the program committees of the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America have organized sessions on current and emerging infectious disease threats during their annual meetings. These sessions explore strategies for the prevention and control of bacteria, viruses, fungi, and parasites that can harm public health. Chapters in are based on recent sessions, focusing on a broad range of infectious agents that pose challenges for the clinical, laboratory, research, public health, and animal health communities.

reflects the diversity of infectious agent threats in the 21st century. Some of these agents have been only recently discovered, such as the . Others are known pathogens presenting new challenges, such as human adenovirus 14. Some infectious agents discussed in the book are currently regional threats, whereas others affect populations around the world. However, every regional threat is potentially a global threat, an issue explored in detail in this edition. Moreover, the book�s discussion of the One World�One Health Initiative underscores the need for a global, multidisciplinary approach in investigating, developing, and implementing solutions.

Each chapter has been contributed by one or more leading experts in infectious diseases, offering perspectives from basic and clinical research, epidemiology, and public health. Despite progress in the prevention and control of infectious diseases during the past several decades, many challenges remain at the same time as new challenges emerge. coverage of current and emerging threats is therefore essential for anyone involved in the fight against infectious diseases, including professionals in microbiology, epidemiology, public health, and clinical and veterinary medicine.

Loading full text...

Full text loading...

/deliver/fulltext/10.1128/9781555816803/fm01.html?itemId=/content/book/10.1128/9781555816803.fm01&mimeType=html&fmt=ahah

Click Here to Take a Look

image of Emerging Infections 9

Microbiology Today

19 June 2013

New and re-appearing parasitic, fungal, bacterial and viral diseases, commonly termed emerging and re-emerging infections, have long been recognized as major problems in human and veterinary medicine. Considerable research efforts are focused on understanding the manifestations and processes behind emerging infections. It is therefore not surprising that this is now the 9th volume of the Emerging Infections series, which is born out of sessions on new and emerging pathogens of the IDSA and ICAAC annual meetings. In 18 chapters written by experts in their respective areas of research, this book addresses a wide range of issues covering clinical aspects, epidemiology and disease symptoms, but more general concepts and novel ideas are also addressed. Emerging Infections 9 is therefore not just of interest to clinicians and others involved in public and veterinary health, but provides a very good overview of recent developments to those working on emerging pathogens or those simply interested in the subject, including students. Not surprisingly, given its global impact, a case study for H1N1 influenza is included, but other chapters dealing with various viral (Hepatitis E, HTLV-1, novel arenavirus infections, HIV-associated malignancies) as well as bacterial (drugresistant bacilli, Arcobacter, buruli ulcer) and parasitic (Plasmodium knowlesi and neglected tropical diseases) infections provide interesting reading. Of particular interest are chapters on the role of cytomegalovirus in transplantation and the challenging hypotheses on the role of giant viruses of algae (mimivirus) in pneumonia. More general chapters deal with infections in long-term care facilities (of increasing importance in Western society) and diseases associated with travel and migration, including the transport of animals. The concept of 'One World-One Health' is explained in a separate chapter which emphasizes the importance of interspecies transmission of pathogens and distribution of disease vectors; this is of increasing importance to Europe and is a must-read to everyone new to the subject for its overall relevance. Interestingly, emerging infectious diseases of plants are described extensively in the final chapter and, although few plant biologists would purchase the book for this alone, it makes for very interesting reading to those less familiar with the subject. This book is highly recommended to anyone interested in keeping up to date with developments in this area of research, but contains enough information to appeal to newcomers.

Society for General Microbiology: Microbiology Today

Reviewer: Alain Kohl, University of Edinburgh

Review Date: February 2011

Doody Enterprises

27 January 2013

At A Glance

Since 1995, the program committees of the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Diseases Society of America have organized sessions on current and emerging infectious disease threats during their annual meetings. These sessions explore strategies for the prevention and control of bacteria, viruses, fungi, and parasites that can harm public health. Chapters in Emerging Infections 9 are based on recent sessions, focusing on a broad range of infectious agents that pose challenges for the clinical, laboratory, research, public health, and animal health communities.

Description

This update on the latest trends in emerging and reemerging infections is partially derived from special sessions during ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy) and IDSA (Infectious Disease Society of America) meetings. The previous edition was published in 2008.

Purpose

This is a valuable source of current information about emerging infections. Given the complexities of the modern world, the emergence of a new infectious agent is a matter of concern for every person involved in the management of infectious diseases, regardless of geographical location. The book is an excellent discussion of the trends in emerging infections over the past two years.

Audience

Any healthcare provider dealing with infectious diseases will find this book helpful. Each chapter is accessible to providers at different levels of expertise. However, some background on the management of infectious diseases makes reading a bit easier. The authors are leading experts in infectious diseases.

Features

The chapters can be divided into three groups: emerging and reemerging infections, new infectious problems in special populations, and a brief discussion of global health. The conditions covered in this book will give readers a good idea of the latest trends in the field of emerging infections, which also makes these updates a necessity. The book has a small number of illustrations, and a separate section with color plates is located between chapters 10 and 11.

Assessment

This is a reference point for other books in this field. It will be difficult for another book on emerging infections to match these authors' level of expertise. New infectious agents will appear, and new problems with old foes will arise. Because of these challenges, new editions of this book will always be necessary.

Doody Enterprises

Reviewer: Carlos Figueroa Castro, MD (Boone Hospital Center)

Review Date: December 2010

©Doody’s Review Service

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error